Cargando…

Days lost due to disability of diclofenac-induced adverse drug reactions

Disability Adjusted Life Years (DALY) is a widely used measure to quantify the burden of diseases or illness. DALYs for a disease is calculated as the sum of the Years of Life Lost (YLL) due to premature mortality in the population and the equivalent healthy Years Lost due to Disability (YLD). The o...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Dixon, Mathew, Molly, Raghavan, C. Vijaya, Mohanta, Guru P., Reddy, Y. Padmanabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798169/
https://www.ncbi.nlm.nih.gov/pubmed/24155815
_version_ 1782287729033216000
author Thomas, Dixon
Mathew, Molly
Raghavan, C. Vijaya
Mohanta, Guru P.
Reddy, Y. Padmanabha
author_facet Thomas, Dixon
Mathew, Molly
Raghavan, C. Vijaya
Mohanta, Guru P.
Reddy, Y. Padmanabha
author_sort Thomas, Dixon
collection PubMed
description Disability Adjusted Life Years (DALY) is a widely used measure to quantify the burden of diseases or illness. DALYs for a disease is calculated as the sum of the Years of Life Lost (YLL) due to premature mortality in the population and the equivalent healthy Years Lost due to Disability (YLD). The only difference from the YLD and Days Lost due to Disability (DLD) calculation is that instead of considering the duration of Adverse Drug Reaction (ADR) in years, it is calculated in days. OBJECTIVE: DLD was measured for diclofenac tablets to prepare the ADR profile. METHODS: The study was done on the patients (18-65 years old) attending the community pharmacy at Kasaragod district, South India, with prescription of diclofenac tablets. Patients reported ADRs on their next visit to the pharmacy or they had called to the provided phone number and reported it. Disability Weight (DW) was calculated in an analogue scale from 0-1. Zero represent complete health and 1 represent death or equivalent condition. DW was multiplied with occurrence and duration of ADRs in days. RESULTS: About 943 patients received diclofenac tablets in 1000 prescriptions were successfully followed up for possible, probable and definite ADRs. A total of 561 reactions reported in 2010 for diclofenac tablet in the study population. There were 34 different types of ADRs under 12 physiological systems/organs. Most common reactions were on gastrointestinal (GI) system (48%), followed by skin (14%), Central Nervous System (10%), renal (7%), and cardiovascular (7%). Abdominal pain, cramps or flatulence was the highest occurring GI ADR (107), followed by 43 rashes, 42 nausea/vomiting, 37 indigestion, 34 peptic ulcers, 31 edema etc. DLD for peptic ulcer was considerably high (0.078) per 1000 of the study population on diclofenac. The most damaging ADR were peptic ulcer with or without perforation, followed by rash 0.036 DLD and edema 0.027 DLD. There was considerable DLD by acute renal failure (0.012) Steven-Johnson syndrome (0.013) even though few cases were reported. CONCLUSIONS: Diclofenac has a complex adverse drug profile. Around 34 types of reactions were reported. Diclofenac was widely prescribed because of the experiential belief of comparative safety with other NSAIDs. The study shows the importance of pharmacovigilance even on the most prescribed medicine. Most disabling ADR for the study population was peptic ulcer with or without perforation. YLD or DLD are useful measures of calculating disability caused by ADRs. Future studies could focus on improving the usefulness & precision of DLD.
format Online
Article
Text
id pubmed-3798169
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-37981692013-10-23 Days lost due to disability of diclofenac-induced adverse drug reactions Thomas, Dixon Mathew, Molly Raghavan, C. Vijaya Mohanta, Guru P. Reddy, Y. Padmanabha Pharm Pract (Granada) Original Research Disability Adjusted Life Years (DALY) is a widely used measure to quantify the burden of diseases or illness. DALYs for a disease is calculated as the sum of the Years of Life Lost (YLL) due to premature mortality in the population and the equivalent healthy Years Lost due to Disability (YLD). The only difference from the YLD and Days Lost due to Disability (DLD) calculation is that instead of considering the duration of Adverse Drug Reaction (ADR) in years, it is calculated in days. OBJECTIVE: DLD was measured for diclofenac tablets to prepare the ADR profile. METHODS: The study was done on the patients (18-65 years old) attending the community pharmacy at Kasaragod district, South India, with prescription of diclofenac tablets. Patients reported ADRs on their next visit to the pharmacy or they had called to the provided phone number and reported it. Disability Weight (DW) was calculated in an analogue scale from 0-1. Zero represent complete health and 1 represent death or equivalent condition. DW was multiplied with occurrence and duration of ADRs in days. RESULTS: About 943 patients received diclofenac tablets in 1000 prescriptions were successfully followed up for possible, probable and definite ADRs. A total of 561 reactions reported in 2010 for diclofenac tablet in the study population. There were 34 different types of ADRs under 12 physiological systems/organs. Most common reactions were on gastrointestinal (GI) system (48%), followed by skin (14%), Central Nervous System (10%), renal (7%), and cardiovascular (7%). Abdominal pain, cramps or flatulence was the highest occurring GI ADR (107), followed by 43 rashes, 42 nausea/vomiting, 37 indigestion, 34 peptic ulcers, 31 edema etc. DLD for peptic ulcer was considerably high (0.078) per 1000 of the study population on diclofenac. The most damaging ADR were peptic ulcer with or without perforation, followed by rash 0.036 DLD and edema 0.027 DLD. There was considerable DLD by acute renal failure (0.012) Steven-Johnson syndrome (0.013) even though few cases were reported. CONCLUSIONS: Diclofenac has a complex adverse drug profile. Around 34 types of reactions were reported. Diclofenac was widely prescribed because of the experiential belief of comparative safety with other NSAIDs. The study shows the importance of pharmacovigilance even on the most prescribed medicine. Most disabling ADR for the study population was peptic ulcer with or without perforation. YLD or DLD are useful measures of calculating disability caused by ADRs. Future studies could focus on improving the usefulness & precision of DLD. Centro de Investigaciones y Publicaciones Farmaceuticas 2012 2012-03-31 /pmc/articles/PMC3798169/ /pubmed/24155815 Text en Copyright © 2012, CIPF http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Thomas, Dixon
Mathew, Molly
Raghavan, C. Vijaya
Mohanta, Guru P.
Reddy, Y. Padmanabha
Days lost due to disability of diclofenac-induced adverse drug reactions
title Days lost due to disability of diclofenac-induced adverse drug reactions
title_full Days lost due to disability of diclofenac-induced adverse drug reactions
title_fullStr Days lost due to disability of diclofenac-induced adverse drug reactions
title_full_unstemmed Days lost due to disability of diclofenac-induced adverse drug reactions
title_short Days lost due to disability of diclofenac-induced adverse drug reactions
title_sort days lost due to disability of diclofenac-induced adverse drug reactions
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798169/
https://www.ncbi.nlm.nih.gov/pubmed/24155815
work_keys_str_mv AT thomasdixon dayslostduetodisabilityofdiclofenacinducedadversedrugreactions
AT mathewmolly dayslostduetodisabilityofdiclofenacinducedadversedrugreactions
AT raghavancvijaya dayslostduetodisabilityofdiclofenacinducedadversedrugreactions
AT mohantagurup dayslostduetodisabilityofdiclofenacinducedadversedrugreactions
AT reddyypadmanabha dayslostduetodisabilityofdiclofenacinducedadversedrugreactions